Metastatic Thymoma Harboring a Deleterious BRCA2 Mutation Derives Durable Clinical Benefit from Olaparib

Thymomas comprise a group of rare epithelial neoplasms of the anterior mediastinum. Whereas localized disease carries a favorable prognosis, the majority of patients with metastatic thymomas experience progression or recurrence over a 10‐year period. Although targeted therapies have become standard...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncologist
Huvudupphovsmän: Principe, Daniel R., Kamath, Suneel D., Munshi, Hidayatullah G., Mohindra, Nisha A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons, Inc. 2019
Ämnen:
Precision Medicine Clinic: Molecular Tumor Board
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7160398/
https://ncbi.nlm.nih.gov/pubmed/32297440
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0393
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk